Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionSevenBridge Financial Group, LLC
Latest Disclosed Ownership6,669 shares
Latest Disclosed Value $ 886,310
SevenBridge Financial Group, LLC reports 0.31% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 23, 2026 - SevenBridge Financial Group, LLC filed a 13F-HR form disclosing ownership of 6,669 shares of Gilead Sciences, Inc. (CH:GILD) valued at $886,310 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 6,690 shares of Gilead Sciences, Inc.. This represents a change in shares of -0.31% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F GILEAD SCIENCES COM 375558103 6,669 -21 -0.31 886 -3.80 0.1385
2026-02-02 2025-12-31 13F GILEAD SCIENCES COM 375558103 6,690 -50 -0.74 922 10.83 0.1482
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 6,740 -1,746 -20.58 832 -18.37 0.1371
2025-09-04 2025-06-30 13F GILEAD SCIENCES COM 375558103 8,486 -210 -2.41 1,018 12.86 0.1796
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 8,696 -1,384 -13.73 903 -6.91 0.1776
2025-02-12 2024-12-31 13F GILEAD SCIENCES COM 375558103 10,080 0 0.00 969 -0.92 0.1833
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 10,080 0 0.00 978 30.92 0.1884
2024-08-09 2024-06-30 13F GILEAD SCIENCES COM 375558103 10,080 -230 -2.23 748 11.99 0.1654
2024-05-10 2024-03-31 13F GILEAD SCIENCES COM 375558103 10,310 -2,875 -21.81 668 -37.55 0.1513
2024-01-22 2023-12-31 13F GILEAD SCIENCES COM 375558103 13,185 -782 -5.60 1,068 2.10 0.2523
2023-10-25 2023-09-30 13F GILEAD SCIENCES COM 375558103 13,967 2,600 22.87 1,047 19.41 0.2705
2023-07-26 2023-06-30 13F GILEAD SCIENCES COM 375558103 11,367 1,847 19.40 876 11.03 0.2262
2023-04-20 2023-03-31 13F GILEAD SCIENCES COM 375558103 9,520 530 5.90 790 2.33 0.2177
2023-01-26 2022-12-31 13F Gilead Sciences COM 375558103 8,990 245 2.80 772 43.04 0.2257
2022-10-17 2022-09-30 13F GILEAD SCIENCES COM 375558103 8,745 8,745 539 0.1826
2020-10-22 2020-09-30 13F Gilead Sciences Equities 375558103 0 -2,667 -100.00 0 -100.00
2020-07-24 2020-06-30 13F Gilead Sciences Equities 375558103 2,667 2,667 205 0.1018
2020-01-17 2019-12-31 13F Gilead Sciences Equities 375558103 0 -3,192 -100.00 0 -100.00
2019-10-09 2019-09-30 13F Gilead Sciences Equities 375558103 3,192 -275 -7.93 202 -13.68 0.1062
2019-07-15 2019-06-30 13F Gilead Sciences Equities 375558103 3,467 -169 -4.65 234 -0.85 0.0838
2019-05-14 2019-03-31 13F Gilead Sciences Equities 375558103 3,636 315 9.49 236 13.46 0.0886
2019-02-14 2018-12-31 13F Gilead Sciences Equities 375558103 3,321 -1,030 -23.67 208 -38.10 0.1273
2018-11-14 2018-09-30 13F Gilead Sciences Equities 375558103 4,351 -86 -1.94 336 7.01 0.1786
2018-08-14 2018-06-30 13F Gilead Sciences Equities 375558103 4,437 -270 -5.74 314 -11.55 0.1749
2018-05-11 2018-03-31 13F Gilead Sciences Equities 375558103 4,707 -155 -3.19 355 2.01 0.2037
2018-02-16 2017-12-31 13F Gilead Sciences Equities 375558103 4,862 270 5.88 348 -6.45 0.1925
2017-11-13 2017-09-30 13F Gilead Sciences Equities 375558103 4,592 1,445 45.92 372 66.82 0.2131
2017-08-14 2017-06-30 13F Gilead Sciences Common Stock 375558103 3,147 -650 -17.12 223 -11.86 0.1361
2017-05-15 2017-03-31 13F Gilead Sciences CS 375558103 3,797 -5,266 -58.10 253 -61.78 0.1662
2017-02-03 2016-12-31 13F Gilead Sciences CS 375558103 9,063 0 0.00 662 0.00 0.4808
2016-12-20 2016-09-30 13F/A-1 Gilead Sciences CS 375558103 9,063 6,918 322.52 662 269.83 0.4823
2016-11-28 2016-09-30 13F Gilead Sciences CS 375558103 9,063 662
2016-08-15 2016-06-30 13F Gilead Sciences CS 375558103 2,145 2,145 179 0.1254
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.